Latest Updates
TRI announces 2023 Translation Fellowships
The Translational Research Institute (TRI) has awarded four Translation Fellowships to early and mid-career researchers. The 12-month Fellowships, valued at $20,000 each, were launched in 2023 as part of TRI’s flagship Translation Pathways program.
CSIRO and TRI award grants to fast-track digital healthcare solutions
The Translational Research Institute (TRI) and the Australia e-Health Research Centre (AEHRC) at CSIRO – Australia’s national science agency, have jointly awarded $300,000 to innovative projects aimed at solving a healthcare challenge.
Medical research boosted with new seed funding awarded to translational clinical collaborations
The Translational Research Institute (TRI) and its hospital partners, Metro South Health (MSH), Mater Research and Children’s Health Queensland (CHQ) have jointly awarded 7 new research grants to drive new clinical collaborations between early-career clinicians and scientists.
An Australian-first initiative of 'bench to bedside' medical research
The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist.
What is Translational Research?
Also known as 'bench-to-bedside' research, it is a type of medical research that focusses on 'translating' basic science discoveries from the laboratory into the clinic.
The aim is to improve how we detect, diagnose and treat health conditions, and improve health outcomes for patients.
At TRI, we work to develop new treatments and diagnostics for conditions ranging from various cancers to autoimmune diseases, and translate these discoveries into improved healthcare.
What's On
2023 Game Changer Series Seminar #3
Renowned Australian rheumatologist and clinical epidemiologist, Professor Rachelle Buchbinder AO FAHMS, will share...
